Metabolism and disposition of the dipeptidyl peptidase IV inhibitor teneligliptin in humans-Reference-Cited by-同舟云学术

Metabolism and disposition of the dipeptidyl peptidase IV inhibitor teneligliptin in humans

Published:2013-07-15 Issue:3 Volume:44 Page:242-253
ISSN:0049-8254
Container-title:Xenobiotica
language:en
Short-container-title:Xenobiotica

Author:

Nakamaru Yoshinobu,Hayashi Yoshiharu,Ikegawa Ruriko,Kinoshita Shuji,Madera Begonya Perez,Gunput Dave,Kawaguchi Atsuhiro,Davies Martin,Mair Stuart,Yamazaki Hiroshi,Kume Toshiyuki,Suzuki Masayuki

Publisher

Informa UK Limited

Subject

Health, Toxicology and Mutagenesis,Pharmacology,Toxicology,Biochemistry,General Medicine

Link

http://www.tandfonline.com/doi/pdf/10.3109/00498254.2013.816891

Reference20 articles.

1. Effect of Renal Insufficiency on the Pharmacokinetics of Sitagliptin, a Dipeptidyl Peptidase-4 Inhibitor

2. Influence of Renal or Hepatic Impairment on the Pharmacokinetics of Saxagliptin

3. Protein Kinase Cζ Activation Mediates Glucagon-Like Peptide-1–Induced Pancreatic β-Cell Proliferation

4. Both Subcutaneously and Intravenously Administered Glucagon-Like Peptide I Are Rapidly Degraded From the NH2-Terminus in Type II Diabetic Patients and in Healthy Subjects

5. Glucagon-like peptide 1 has a physiological role in the control of postprandial glucose in humans: studies with the antagonist exendin 9-39.

Cited by 45 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. QuinuclidineN-Oxygenation Mediated by Flavin-Containing Monooxygenases 1 and 3 in Kidney and Liver Microsomes from Humans, Monkeys, Dogs, and Pigs;Drug Metabolism and Disposition;2024-05-20

2. Molecular and functional characterization of flavin-containing monooxygenases (FMO1–6) in tree shrews;Comparative Biochemistry and Physiology Part C: Toxicology & Pharmacology;2024-03

3. A variety of cytochrome P450 enzymes and flavin-containing monooxygenases in dogs and pigs commonly used as preclinical animal models;Biochemical Pharmacology;2024-03

4. Evaluation of Age-Related Changes in Teneligliptin Pharmacokinetics in Japanese and European Descent Subjects Using a Physiologically Based Pharmacokinetic Model;Diabetes Therapy;2023-12-20

5. Simple confirmation methods for rare but impaired variants of human flavin-containing monooxygenase 3 (FMO3) found in an updated genome resource databank;Drug Metabolism and Pharmacokinetics;2023-12